An NCI-designated Comprehensive Cancer Center

Hua Yu, Ph.D.

Billy and Audrey L. Wilder Professor in Tumor Immunotherapy; Associate Chair and Professor, Department of Immuno-Oncology; Co-leader, Cancer Immunotherapeutics Program, Comprehensive Cancer Center
Research Focus
  • Role of Stat3 in Tumor Angiogenesis and Tumor Immune Evasion
  • Cancer Biology
  • Identifying the Connection between Stat3 and Diabetes
  • Tumor Immunology

Research Teams

Dr. Yu's laboratory was the first to validate STAT3, a critical regulator of tumor cell survival and proliferation, as a molecular target for cancer therapy in animal models. Yu's team also unraveled a critical role of STAT3 in tumor angiogenesis and tumor immune evasion.


City of Hope Comprehensive Cancer Center, 1500 East Duarte Road

Duarte, CA 91010

In The News
An Expert's Voice
City of Hope News

City of Hope signs licensing agreement with Scopus BioPharma Inc. to develop novel, targeted immuno-oncology gene therapy

Oncotripsy | City of Hope

Using ultrasound to kill cancer cells

Saul Priceman | City of Hope

What Is Immunotherapy?